In January 2024, Novozymes and Chr. Hansen completed their merger to form Novonesis, a global biosolutions leader. This strategic combination aims to accelerate innovation in enzymes and microbial solutions by leveraging the strengths of both companies. The new entity is expected to provide more sustainable and efficient products across industries, including food, agriculture, and leather processing. By uniting advanced research capabilities and commercial reach, Novonesis enhances its ability to address global challenges such as climate change and resource efficiency. This merger is anticipated to strengthen market competitiveness and drive long-term growth in the biosolutions sector
